Edition:
United Kingdom

Infant Bacterial Therapeutics AB (IBTb.ST)

IBTb.ST on Stockholm Stock Exchange

263.00SEK
5:00pm BST
Change (% chg)

2.50kr (+0.96%)
Prev Close
260.50kr
Open
260.50kr
Day's High
269.00kr
Day's Low
259.50kr
Volume
5,619
Avg. Vol
10,000
52-wk High
274.50kr
52-wk Low
115.00kr

About

Infant Bacterial Therapeutics AB is a Sweden-based company, which is primarily involved in the pharmaceutical industry. The Company develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of... (more)

Overall

Beta: 1.99
Market Cap(Mil.): kr2,826.02
Shares Outstanding(Mil.): 10.85
Dividend: --
Yield (%): --

Financials

  IBTb.ST Industry Sector
P/E (TTM): -- 30.33 34.23
EPS (TTM): -2.86 -- --
ROI: -5.61 12.99 12.65
ROE: -5.61 14.18 17.19

BRIEF-Infant Bacterial Therapeutics AB Announces First Distribution Agreement

* SIGNED FIRST DISTRIBUTION AGREEMENT FOR IBP-9414 WITH MEGAPHARM LTD. FOR THE ISRAELI MARKET AND THE PALESTINIAN AUTHORITY'S TERRITORIES

06 Mar 2019

Earnings vs. Estimates